Guideline for the Prevention and Treatment of Anticipatory Nausea and Vomiting due to Chemotherapy in Pediatric Cancer Patients
This guideline represents the third of a series of guidelines to address the need for, and the selection of, antiemetic prophylaxis and intervention in children with cancer receiving chemotherapy. This evidence-based guideline for anticipatory CINV prevention and management is presented with the intention of optimizing the control of anticipatory CINV in children receiving chemotherapy.
View this guideline through open access published in Pediatric Blood and Cancer.
View the full guideline POGO Anticipatory CINV Guideline.